Clinical Trials Sponsored by Sahajanand Medical Technologies Limited

Total 17 results

Sahajanand Medical Technologies Limited

Recruiting

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Coronary Artery Disease

Netherlands
Sahajanand Medical Technologies Limited
Clinica Di Montevergine

Recruiting

Hydra Registry - Italy Experience

Aortic Valve Stenosis

Italy
Sahajanand Medical Technologies Limited
Qmed Consulting A/S

Not yet recruiting

Hydra Single-centre Experience - Copenhagen, Denmark

Aortic Valve Stenosis

Denmark
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Supralimus-Core™ Pharmacokinetic (PK) Study

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.

Completed

A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute (Maximus)

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Sahajanand Medical Technologies Limited
Cardiovascular European Research Center (CERC)

Completed

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

Coronary Artery Disease

Switzerland, Germany, France
Insel Gruppe AG, University Hospital Bern
Sahajanand Medical Technologies Limited

Recruiting

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation (MATRIX-2)

Atrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 Inhibitor

Spain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
Pieter C.Smits
Sahajanand Medical Technologies Limited

Completed

Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population

Cardiac Disease | PCI | High Bleeding Risk

Netherlands
Sahajanand Medical Technologies Pvt. Ltd.
CMS Medical

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Coronary Restenosis

Brazil
ECRI bv
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT)

Coronary Stenosis

Bulgaria, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
Cedars-Sinai Medical Center
11 Heath and Technologies Limited

Withdrawn

Combining Ostom-I With Abstats Sensors to Improve Prediction of Ostomy Output

Ostomy
UMC Utrecht
Institut National de la Santé Et de la Recherche Médicale, France; Philips... and other collaborators

Completed

Liquid Biopsies and Imaging in Breast Cancer (LIMA)

Breast Cancer

Netherlands
University of Cambridge
Assistance Publique - Hôpitaux de Paris; Cardiff University; Lund University; Institut... and other collaborators

Completed

TRANSEURO Open Label Transplant Study in Parkinson's Disease (TRANSEURO)

Parkinson's Disease
Fondazione del Piemonte per l'Oncologia
National Cancer Institute (NCI); University of Pisa; Royal Marsden NHS Foundation... and other collaborators

Recruiting

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer Aggressiveness

Italy

Clinical Trials Sponsored by Sahajanand Medical Technologies Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations